Envoy Medical (COCHW) Equity Ratio (2020 - 2026)

Envoy Medical's Equity Ratio history runs 7 years deep, the most recent figure standing at 0.34 for Q1 2026.

• In Q1 2026, Equity Ratio rose 114.61% year-over-year to 0.34; the TTM figure through Mar 2026 stood at 0.34 (up 114.61% YoY), while the FY2025 annual figure was 1.42, up 13.01% from the prior year.
• Equity Ratio came in at 0.34 for Q1 2026 at Envoy Medical, up from 1.42 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.34 in Q1 2026 to a low of 14.16 in Q4 2022.
• A 5-year average of 1.77 and a median of 1.0 in 2023 frame the typical range for Equity Ratio.
• Across the five-year window, Equity Ratio sank 13345.94% in 2022 and jumped 477.81% in 2023, its largest moves.
• Envoy Medical's Equity Ratio stood at 14.16 in 2022, then soared by 98.48% to 0.21 in 2023, then slumped by 660.52% to 1.63 in 2024, then climbed by 13.01% to 1.42 in 2025, then soared by 123.98% to 0.34 in 2026.
• According to Business Quant data, Equity Ratio over the past three periods registered 0.34, 1.42, and 0.94 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison